Clinical Investigation for Safety and Efficacy Study of CELT ACD (Arterial ClosureDevice)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 241 participants.
Also called NCT01600482
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose supportive care
- Phase
- Not applicable
- Enrolled
- 241 participants
- Sponsor
- Vasorum Ltd
- Registry
-
NCT01600482
-
- Other papers using this trial's data
- A multicenter randomized trial comparing the effectiveness and safety of a novel vascular closure device to manual compression in anticoagulated patients undergoing percutaneous transfemoral procedures: The CELT ACD trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Germany, Ireland
- Registry status
- Completed
Technical summary
Registry record NCT01600482. Randomized; no masking; primary purpose supportive care. Start 2012-05 (registry gives no type); primary completion 2016-02 (actual). Results posted on 2017-08-23.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Investigation for Safety and Efficacy Study of CELT ACD (Arterial ClosureDevice)
- Condition
- Cardiac Disease
- Condition
- Coronary Artery Disease
- Intervention (Device)
- CELT ACD
- Lead sponsor
- Vasorum Ltd
Record details
- Record id
cardio:ct-nct01600482- Content hash
4a9bd3378dccc85a9db35d6074998c4c1c30146ebdecdbce65f4bd160fe892df